Egot, Alghen F.

HRN: 22-19-66  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2023
MUPIROCIN 2%, 15G (TUBE)
01/17/2023
01/23/2023
TOPICAL
1squirt
BID
Bed Sores
Waiting Final Action 
01/19/2023
CEFTRIAXONE 1G (VIAL)
01/19/2023
01/25/2023
IV
2g
Q24H
Pelvic Inflammatory Disease
Waiting Final Action 
01/21/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/21/2023
01/27/2023
IV
600mg
Q8
Cholecystitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: